Literature DB >> 28987030

Identifying HIPK1 as Target of miR-22-3p Enhancing Recombinant Protein Production From HEK 293 Cell by Using Microarray and HTP siRNA Screen.

Sarah Inwood1,2, Eugen Buehler3, Michael Betenbaugh2, Madhu Lal3, Joseph Shiloach1.   

Abstract

Protein expression from human embryonic kidney cells (HEK 293) is an important tool for structural and clinical studies. It is previously shown that microRNAs (small, noncoding RNAs) are effective means for improved protein expression from these cells, and by conducting a high-throughput screening of the human microRNA library, several microRNAs are identified as potential candidates for improving expression. From these, miR-22-3p is chosen for further study since it increased the expression of luciferase, two membrane proteins and a secreted fusion protein with minimal effect on the cells' growth and viability. Since each microRNA can interact with several gene targets, it is of interest to identify the repressed genes for understanding and exploring the improved expression mechanism for further implementation. Here, the authors describe a novel approach for identification of the target genes by integrating the differential gene expression analysis with information obtained from our previously conducted high-throughput siRNA screening. The identified genes were validated as being involved in improving luciferase expression by using siRNA and qRT-PCR. Repressing the target gene, HIPK1, is found to increase luciferase and GPC3 expression 3.3- and 2.2-fold, respectively.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIPK1; miR-22-3p; microRNA; microarray; protein expression; siRNA

Mesh:

Substances:

Year:  2017        PMID: 28987030      PMCID: PMC5823020          DOI: 10.1002/biot.201700342

Source DB:  PubMed          Journal:  Biotechnol J        ISSN: 1860-6768            Impact factor:   4.677


  48 in total

1.  Common seed analysis to identify off-target effects in siRNA screens.

Authors:  Shane Marine; Amit Bahl; Marc Ferrer; Eugen Buehler
Journal:  J Biomol Screen       Date:  2011-11-15

2.  EMILIN-3, peculiar member of elastin microfibril interface-located protein (EMILIN) family, has distinct expression pattern, forms oligomeric assemblies, and serves as transforming growth factor β (TGF-β) antagonist.

Authors:  Alvise Schiavinato; Ann-Kathrin A Becker; Miriam Zanetti; Diana Corallo; Martina Milanetto; Dario Bizzotto; Giorgio Bressan; Marija Guljelmovic; Mats Paulsson; Raimund Wagener; Paola Braghetta; Paolo Bonaldo
Journal:  J Biol Chem       Date:  2012-02-10       Impact factor: 5.157

3.  CHO cell culture longevity and recombinant protein yield are enhanced by depletion of miR-7 activity via sponge decoy vectors.

Authors:  Noelia Sanchez; Paul Kelly; Clair Gallagher; Nga T Lao; Colin Clarke; Martin Clynes; Niall Barron
Journal:  Biotechnol J       Date:  2013-12-10       Impact factor: 4.677

4.  Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens.

Authors:  Andrea Franceschini; Roger Meier; Alain Casanova; Saskia Kreibich; Neha Daga; Daniel Andritschke; Sabrina Dilling; Pauli Rämö; Mario Emmenlauer; Andreas Kaufmann; Raquel Conde-Álvarez; Shyan Huey Low; Lucas Pelkmans; Ari Helenius; Wolf-Dietrich Hardt; Christoph Dehio; Christian von Mering
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

5.  Enhanced protein production by microRNA-30 family in CHO cells is mediated by the modulation of the ubiquitin pathway.

Authors:  Simon Fischer; Sven Mathias; Simone Schaz; Verena Vanessa Emmerling; Theresa Buck; Michael Kleemann; Matthias Hackl; Johannes Grillari; Armaz Aschrafi; René Handrick; Kerstin Otte
Journal:  J Biotechnol       Date:  2015-08-06       Impact factor: 3.307

6.  SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.

Authors:  X Li; Y Luo; L Yu; Y Lin; D Luo; H Zhang; Y He; Y-O Kim; Y Kim; S Tang; W Min
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

7.  HIPK1 interacts with c-Myb and modulates its activity through phosphorylation.

Authors:  Vilborg Matre; Oddmund Nordgård; Anne Hege Alm-Kristiansen; Marit Ledsaak; Odd Stokke Gabrielsen
Journal:  Biochem Biophys Res Commun       Date:  2009-07-30       Impact factor: 3.575

Review 8.  Engineering cells to improve protein expression.

Authors:  Su Xiao; Joseph Shiloach; Michael J Betenbaugh
Journal:  Curr Opin Struct Biol       Date:  2014-04-03       Impact factor: 6.809

9.  Multiple protein-protein interactions converging on the Prp38 protein during activation of the human spliceosome.

Authors:  Tonio Schütze; Alexander K C Ulrich; Luise Apelt; Cindy L Will; Natascha Bartlick; Martin Seeger; Gert Weber; Reinhard Lührmann; Ulrich Stelzl; Markus C Wahl
Journal:  RNA       Date:  2015-12-16       Impact factor: 4.942

Review 10.  Recent advances in technology supporting biopharmaceutical production from mammalian cells.

Authors:  M Butler; A Meneses-Acosta
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-05       Impact factor: 4.813

View more
  3 in total

1.  Improved protein expression in HEK293 cells by over-expressing miR-22 and knocking-out its target gene, HIPK1.

Authors:  Sarah Inwood; Laura Abaandou; Michael Betenbaugh; Joseph Shiloach
Journal:  N Biotechnol       Date:  2019-08-16       Impact factor: 5.079

2.  Knocking out Ornithine Decarboxylase Antizyme 1 (OAZ1) Improves Recombinant Protein Expression in the HEK293 Cell Line.

Authors:  Laura Abaandou; Joseph Shiloach
Journal:  Med Sci (Basel)       Date:  2018-06-08

3.  Pathogenic impact of transcript isoform switching in 1,209 cancer samples covering 27 cancer types using an isoform-specific interaction network.

Authors:  Abdullah Kahraman; Tülay Karakulak; Damian Szklarczyk; Christian von Mering
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.